The biggest litigation impacting the healthcare industry
Above the Law and Lake Whillans take a deep dive into multibillion-dollar disputes involving pay-for-delay agreements, opioids, and other areas.
The litigation shaping the healthcare industry landscape
While the ultimate litigation effects of the COVID-19 pandemic remain to be seen, the current high-profile healthcare claims are as varied as product liability and mass tort actions, antitrust and patent cases, and disputes involving the Affordable Care Act.
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Finding a way through a tight deal space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
Navigating the Life Science M&A Savannah
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.
Collaboration at Fenwick & West Steers Firm through complex deals
After a relatively slow 2016 for life sciences deals...
Heard at HLTH 2024: Insights from Innovative Healthcare Executives
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Newly united Arnold & Porter Kaye Scholer surveys changed life sciences deal environment
Last year proved a slow one for dealmaking in the life sciences space. But that didn’t stop two of the major legal players in it from consummating one themselves: In November, Arnold & Porter and Kaye Scholer agreed to merge, bringing together two formidable healthcare practices.
Insurance Companies Can Find Relief During Delay of Loss Reimbursement
Lake Whillans is providing financial relief to insurance companies that offered plans on the Affordable Care Act’s health insurance exchanges and are now impaired by the government’s delay in making promised so-called “risk corridor payments.”
The Personal Touch In Patent Prosecution
When it comes to fighting disease, Michael Shuster takes things personally...
Report: Corporate venture capital bullish on seed stage health investments
Corporate venture investment has emerged as an important alternative to more traditional healthcare funding avenues. However, there's still a dearth of information about their activity.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Aggregate Spend Goes Global
This independent editorial series on healthcare and the law is sponsored by Lake Whillans, a distressed venture capital and litigation finance firm that helps companies facing litigation or arbitration. As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift […]
Friends and Family (Offices) Step in to Funding Drought
Not too long ago, it didn’t take much for someone with an idea for a new medical device to rake in the early-stage funding. Investors have been a bit more discerning over the past decade, to say the least, and by and large they remain so, according to K&L Gates’ Michael Hedge, who’s been around long enough to […]
M&A: The Last Refuge for Biotechs Seeking Funding
These are tough times in the biotech and pharmaceutical industries: Funding is drying up, investors are fleeing the space, the IPO door is pretty firmly shut, valuations are dropping, activists are lurking and the headlines are anything but kind. But when the going gets tough, the tough consider strategic alternatives. Stuart Falber and Belinda Juran, […]
Wilson Sonsini, WilmerHale and Cooley top new Life Sciences Law Firm Index
The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few industries where companies insist on industry-specialized advisors. The complex life cycle of a life sciences product demands a broad range of legal and business expertise across many practice specialties, combined with deep scientific knowledge. The stakes are increasing particularly when […]
Meet the Mt. Rushmore of healthcare corporate venture capital
Throughout the year Lake Whillans, with the help of MedCity News, has explored two key issues for healthcare investors and entrepreneurs: trust and reliability. We’ve helped bring to light some harrowing war stories of partnerships gone bad. We’ve also asked healthcare leaders in the trenches about the best ways to operate in the modern healthcare […]